168 related articles for article (PubMed ID: 18031728)
1. Hypotensive effect of UDP on intraocular pressure in rabbits.
Markovskaya A; Crooke A; Guzmán-Aranguez AI; Peral A; Ziganshin AU; Pintor J
Eur J Pharmacol; 2008 Jan; 579(1-3):93-7. PubMed ID: 18031728
[TBL] [Abstract][Full Text] [Related]
2. Adenosine tetraphosphate, Ap4, a physiological regulator of intraocular pressure in normotensive rabbit eyes.
Pintor J; Peláez T; Peral A
J Pharmacol Exp Ther; 2004 Feb; 308(2):468-73. PubMed ID: 14600249
[TBL] [Abstract][Full Text] [Related]
3. Adenine nucleotide effect on intraocular pressure: Involvement of the parasympathetic nervous system.
Peral A; Gallar J; Pintor J
Exp Eye Res; 2009 Jun; 89(1):63-70. PubMed ID: 19250934
[TBL] [Abstract][Full Text] [Related]
4. Effect of diinosine polyphosphates on intraocular pressure in normotensive rabbits.
Guzman-Aranguez A; Díez LM; Martín-Gil A; Gualix J; Miras-Portugal MT; Pintor J
Exp Eye Res; 2012 Aug; 101():49-55. PubMed ID: 22677090
[TBL] [Abstract][Full Text] [Related]
5. Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits.
Alarma-Estrany P; Crooke A; Mediero A; Peláez T; Pintor J
J Pineal Res; 2008 Nov; 45(4):468-75. PubMed ID: 18673419
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterisation of pyrimidinoceptor responses in NG108-15 cells.
Sak K; Samuel K; Kelve M; Webb TE
Eur J Pharmacol; 2001 Mar; 415(2-3):127-33. PubMed ID: 11274990
[TBL] [Abstract][Full Text] [Related]
7. Silencing of P2Y(2) receptors reduces intraocular pressure in New Zealand rabbits.
Martin-Gil A; de Lara MJ; Crooke A; Santano C; Peral A; Pintor J
Br J Pharmacol; 2012 Feb; 165(4b):1163-72. PubMed ID: 21740413
[TBL] [Abstract][Full Text] [Related]
8. Identification of the P2Y(12) receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides.
Nicholas RA
Mol Pharmacol; 2001 Sep; 60(3):416-20. PubMed ID: 11502870
[No Abstract] [Full Text] [Related]
9. Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma.
Pintor J
Curr Opin Investig Drugs; 2005 Jan; 6(1):76-80. PubMed ID: 15675606
[TBL] [Abstract][Full Text] [Related]
10. A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.
Jacob TF; Singh V; Dixit M; Ginsburg-Shmuel T; Fonseca B; Pintor J; Youdim MBH; Major DT; Weinreb O; Fischer B
Purinergic Signal; 2018 Sep; 14(3):271-284. PubMed ID: 30019187
[TBL] [Abstract][Full Text] [Related]
11. UTP and diadenosine tetraphosphate accelerate wound healing in the rabbit cornea.
Pintor J; Bautista A; Carracedo G; Peral A
Ophthalmic Physiol Opt; 2004 May; 24(3):186-93. PubMed ID: 15130167
[TBL] [Abstract][Full Text] [Related]
12. The effect of topical diltiazem on the intraocular pressure in betamethasone-induced ocular hypertensive rabbits.
Melena J; Santafé J; Segarra J
J Pharmacol Exp Ther; 1998 Jan; 284(1):278-82. PubMed ID: 9435188
[TBL] [Abstract][Full Text] [Related]
13. Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.
Shinozaki Y; Kashiwagi K; Namekata K; Takeda A; Ohno N; Robaye B; Harada T; Iwata T; Koizumi S
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978804
[TBL] [Abstract][Full Text] [Related]
14. Distinct P2Y receptor subtypes regulate calcium signaling in human retinal pigment epithelial cells.
Tovell VE; Sanderson J
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):350-7. PubMed ID: 18172112
[TBL] [Abstract][Full Text] [Related]
15. Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits.
Alarma-Estrany P; Guzman-Aranguez A; Huete F; Peral A; Plourde R; Pelaez T; Yerxa B; Pintor J
J Pharmacol Exp Ther; 2011 Jun; 337(3):703-9. PubMed ID: 21368006
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
Exp Eye Res; 2009 Mar; 88(3):504-11. PubMed ID: 19056382
[TBL] [Abstract][Full Text] [Related]
17. Presence of diadenosine polyphosphates in the aqueous humor: their effect on intraocular pressure.
Pintor J; Peral A; Peláez T; Martín S; Hoyle CH
J Pharmacol Exp Ther; 2003 Jan; 304(1):342-8. PubMed ID: 12490610
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the biological activities of uridine diphosphate in human dendritic cells: Influence on chemotaxis and CXCL8 release.
Idzko M; Panther E; Sorichter S; Herouy Y; Berod L; Geissler M; Mockenhaupt M; Elsner P; Girolomoni G; Norgauer J
J Cell Physiol; 2004 Nov; 201(2):286-93. PubMed ID: 15334663
[TBL] [Abstract][Full Text] [Related]
19. UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
Ginsburg-Shmuel T; Haas M; Grbic D; Arguin G; Nadel Y; Gendron FP; Reiser G; Fischer B
Bioorg Med Chem; 2012 Sep; 20(18):5483-95. PubMed ID: 22901672
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic and response sensitization modeling of the intraocular pressure-lowering effect of the EP4 Agonist 5-{3-[(2S)-2-{(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]butyl}-5-oxopyrrolidin-1-yl]propyl}thiophene-2-carboxylate (PF-04475270).
Luu KT; Zhang EY; Prasanna G; Xiang C; Anderson S; Fortner J; Vicini P
J Pharmacol Exp Ther; 2009 Nov; 331(2):627-35. PubMed ID: 19690190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
